ATE78482T1 - Substituierte hexahydroarylchinolizine. - Google Patents
Substituierte hexahydroarylchinolizine.Info
- Publication number
- ATE78482T1 ATE78482T1 AT87307541T AT87307541T ATE78482T1 AT E78482 T1 ATE78482 T1 AT E78482T1 AT 87307541 T AT87307541 T AT 87307541T AT 87307541 T AT87307541 T AT 87307541T AT E78482 T1 ATE78482 T1 AT E78482T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- hexahydroarylquinolizine
- disorders
- certain
- hexahydroarylquinolizines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90148586A | 1986-08-28 | 1986-08-28 | |
| EP87307541A EP0259092B1 (de) | 1986-08-28 | 1987-08-26 | Substituierte Hexahydroarylchinolizine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE78482T1 true ATE78482T1 (de) | 1992-08-15 |
Family
ID=25414273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87307541T ATE78482T1 (de) | 1986-08-28 | 1987-08-26 | Substituierte hexahydroarylchinolizine. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0259092B1 (de) |
| JP (1) | JP2582799B2 (de) |
| KR (1) | KR880002869A (de) |
| AT (1) | ATE78482T1 (de) |
| AU (1) | AU597412B2 (de) |
| CA (1) | CA1288435C (de) |
| DE (1) | DE3780542T2 (de) |
| DK (1) | DK447387A (de) |
| ES (1) | ES2044944T3 (de) |
| GR (1) | GR3005537T3 (de) |
| IL (1) | IL83586A (de) |
| NZ (1) | NZ221485A (de) |
| PT (1) | PT85593B (de) |
| ZA (1) | ZA876400B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4942235A (en) * | 1989-03-16 | 1990-07-17 | Merck & Co., Inc. | Process for certain (2R-trans)hexahydroaroquinolizines |
| US5229387A (en) * | 1991-09-20 | 1993-07-20 | Syntex (U.S.A.) Inc. | Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives |
| FR2744451B1 (fr) * | 1996-02-01 | 1998-04-24 | Pf Medicament | Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique |
| US6141745A (en) * | 1998-04-30 | 2000-10-31 | Advanced Micro Devices, Inc. | Functional bit identifying a prefix byte via a particular state regardless of type of instruction |
| FI126838B (en) | 2014-12-16 | 2017-06-15 | Vetcare Oy | Process for the preparation of spirocyclic substituted benzofuroquinolizines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1435573A (en) * | 1973-05-25 | 1976-05-12 | Wyeth John & Brother Ltd | Indoloquinolizines |
| GB2106909B (en) * | 1981-10-07 | 1984-09-19 | Wyeth John & Brother Ltd | Benzoquinolizines |
| IE57014B1 (en) * | 1983-03-25 | 1992-03-11 | Wyeth John & Brother Ltd | Benzoquinolizines |
| IL74147A (en) * | 1984-02-02 | 1988-08-31 | Merck & Co Inc | 2-acylamino-hexahydro-arylquinolizines and salts thereof and pharmaceutical compositions containing them |
| NZ216283A (en) * | 1985-06-03 | 1989-10-27 | Merck & Co Inc | Hexahydro arylquinolizine derivatives and pharmaceutical compositions |
-
1987
- 1987-08-18 NZ NZ221485A patent/NZ221485A/en unknown
- 1987-08-19 AU AU77205/87A patent/AU597412B2/en not_active Ceased
- 1987-08-19 IL IL83586A patent/IL83586A/xx not_active IP Right Cessation
- 1987-08-26 PT PT85593A patent/PT85593B/pt not_active IP Right Cessation
- 1987-08-26 DE DE8787307541T patent/DE3780542T2/de not_active Expired - Fee Related
- 1987-08-26 AT AT87307541T patent/ATE78482T1/de active
- 1987-08-26 CA CA000545453A patent/CA1288435C/en not_active Expired - Fee Related
- 1987-08-26 ES ES87307541T patent/ES2044944T3/es not_active Expired - Lifetime
- 1987-08-26 EP EP87307541A patent/EP0259092B1/de not_active Expired - Lifetime
- 1987-08-27 ZA ZA876400A patent/ZA876400B/xx unknown
- 1987-08-27 DK DK447387A patent/DK447387A/da not_active Application Discontinuation
- 1987-08-28 KR KR870009444A patent/KR880002869A/ko not_active Application Discontinuation
- 1987-08-28 JP JP62214979A patent/JP2582799B2/ja not_active Expired - Lifetime
-
1992
- 1992-08-27 GR GR920401865T patent/GR3005537T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3780542T2 (de) | 1993-01-07 |
| AU7720587A (en) | 1988-03-03 |
| CA1288435C (en) | 1991-09-03 |
| JP2582799B2 (ja) | 1997-02-19 |
| PT85593A (en) | 1987-09-01 |
| DK447387D0 (da) | 1987-08-27 |
| IL83586A0 (en) | 1988-01-31 |
| GR3005537T3 (de) | 1993-06-07 |
| KR880002869A (ko) | 1988-05-12 |
| DE3780542D1 (en) | 1992-08-27 |
| NZ221485A (en) | 1991-04-26 |
| DK447387A (da) | 1988-02-29 |
| ES2044944T3 (es) | 1994-01-16 |
| JPS63139183A (ja) | 1988-06-10 |
| EP0259092A1 (de) | 1988-03-09 |
| EP0259092B1 (de) | 1992-07-22 |
| AU597412B2 (en) | 1990-05-31 |
| ZA876400B (en) | 1988-02-25 |
| PT85593B (pt) | 1990-05-31 |
| IL83586A (en) | 1991-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI925549A (fi) | Nya azaheterocyklylmetyl-kromaner | |
| DE3779500T2 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
| ATE211743T1 (de) | Substituierte 3-aminochinuclidine | |
| ES2078440T3 (es) | Compuestos farmaceuticos. | |
| ATE119522T1 (de) | Substituierte cyclohexanole mit zentraler nervensystemwirkung. | |
| NO166362C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater. | |
| HK1019326A1 (en) | Aryl substituted cyclic amines as selective dopamine d3 ligands. | |
| ATE222763T1 (de) | Verwendung von imidazo-(1,2-a)-pyridin-3-acetamid-derivaten für die therapeutische behandlung von neuropsychiatrischen syndromen in zusammenhang mit störungen der nervenbahnen der basalganglien | |
| FI965021A (fi) | Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa | |
| NO863671D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. | |
| NO870998D0 (no) | Fremgangsmaate for fremstilling av nye, terapeutisk aktive acetamid-derivater. | |
| IT8848251A0 (it) | Composti correlati all'acetozolammi de con attivita' inibitrice dell'anidrasi carbonica, utili in particolare nel trattamento del glaucoma | |
| ES2044944T3 (es) | Hexahidroarilquinolizinas sustituidas. | |
| NO924547L (no) | Piperidylmetyl-substituerte chromanderivater | |
| DK0431579T3 (da) | Substituerede cyclohexener som midler med virkning på centralnervesystemet | |
| NO167456C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre | |
| NO953892D0 (no) | Imidazolokinoksalinon-derivater som EAA-antagonister | |
| SE8301038L (sv) | Tiopyranopyrimidinforeningar och syraadditionssalter derav | |
| DE3483944D1 (de) | Verwendung von selektiv peripheren dopamin-antagonisten zur herstellung eines arzneimittels zur topischen behandlung von okularer hypertension. | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| NO166447C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid. | |
| MX5313A (es) | Derivados heterociclicos para el tratamiento de trastornos cardiovasculares y procedimiento para obtenerlos. | |
| DE3685988T2 (de) | Verwendung von "naftidrofuryl" zur behandlung von neuropathien. |